Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
CN¥11.83 - CN¥18.41
Next Earnings Date
Aug 25 2025 (Estimate)
Next Earnings Date
Aug 25 2025 (Est.)
Latest price
Market Cap | CN¥12.38B |
EV | CN¥10.11B |
Shares Outstanding | 889.45M |
Beta | 0.46 |
Analyst Rating | BUY |
Analyst Target Price | CN¥16.28 |
P/E 2025E | 12.24x |
P/Revenue 2025E | 2.07x |
Revenue | 8.30% |
EPS | -3.60% |
Operating Cash Flow | 13.50% |
Free Cash Flow | - |
Revenue | 7.20% |
EPS | 17.00% |
Operating Cash Flow | 14.10% |
Free Cash Flow | - |
Gross Margin 2025E | 35.59% |
Net Profit Margin 2025E | 15.30% |
ROE 2025E | 9.89% |
ROCE 2024 | 7.13% |
DPS 2025E | CN¥0.42 |
Payout Ratio 2025E | 36.84% |
Div. Yield 2025E | 3.04% |
DPS Last 3Y CAGR | 6.30% |
Price
%
1M
3M
6M
1Y
3Y
5Y
Zhejiang Jiuzhou Pharmaceutical Co., Ltd
603456
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mei, Yi Jiang
Employees
5,001
Website
www.jiuzhoupharma.comIPO Date
2014-10-10
Headquarters
99 Waisha Road, Jiaojiang District, Taizhou, Zhejiang Province, 318000, China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved